Dr Reddys Laboratories (RDY) Cash & Equivalents Growth (5y) (2014 - 2026)
Dr Reddys Laboratories (RDY) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.84 Bn | 9.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.18% |
| Mar 31, 2025 | 44.82% |
| Mar 31, 2024 | 21.58% |
| Jun 30, 2023 | 24.51% |
| Mar 31, 2023 | 17.21% |
| Jun 30, 2022 | 1,704.16% |
| Mar 31, 2022 | 23,272.76% |
| Dec 31, 2020 | -12.73% |
| Sep 30, 2020 | -7.03% |
| Mar 31, 2020 | -46.64% |
| Dec 31, 2019 | -94.28% |
| Sep 30, 2019 | -1.31% |
| Dec 31, 2018 | -6.56% |
| Jun 30, 2018 | -61.62% |
| Mar 31, 2018 | -1.50% |
| Dec 31, 2017 | 582.30% |
| Sep 30, 2017 | 562.29% |
| Jun 17, 2017 | -97.46% |
| Mar 17, 2017 | -99.61% |
| Dec 31, 2016 | 608.92% |